Stock Track | Intellia Therapeutics Soars 6.24% in Pre-market on Analyst Bullish Call

Stock Track
03/02

Intellia Therapeutics (NTLA) stock soared 6.24% in pre-market trading on Monday, showing significant upward momentum ahead of the regular session.

The surge appears driven by a positive analyst action, with H.C. Wainwright analyst Mitchell Kapoor reiterating a Buy rating on the company and setting a price target of $25.00.

Such analyst endorsements often influence investor sentiment, particularly in pre-market activity, as they provide forward-looking assessments of a company's value and prospects.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10